Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case series-Reference-Cited by-同舟云学术

Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case series

Published:2024-08-13 Issue: Volume: Page:
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Ugradar Shoaib,Parunakian Emanuil,Malkhasyan Emil,Raika Pershanjit,Tolentino Joseph,Kossler Andrea L.,Cockerham Kimberly,Amarikwa Linus,Weinberg David A.,Douglas Raymond S.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00417-024-06599-3.pdf

Reference17 articles.

1. Muñoz-Ortiz J, Sierra-Cote MC, Zapata-Bravo E et al (2020) Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature. Syst Reviews 9. https://doi.org/10.1186/S13643-020-01459-7

2. Kashkouli MB, Pakdel F, Kiavash V et al (2011) Hyperthyroid vs hypothyroid eye disease: the same severity and activity. Eye 25:1442. https://doi.org/10.1038/EYE.2011.186

3. Eckstein AK, Lösch C, Glowacka D et al (2009) Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol 93:1052–1056. https://doi.org/10.1136/BJO.2007.137265

4. Perros P, Žarković MP, Panagiotou GC et al (2020) Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study. J Endocrinol Investig. https://doi.org/10.1007/s40618-020-01258-w

5. Tsui S, Naik V, Hoa N et al (2008) Evidence for an association between thyroid-stimulating hormone and insulin-like Growth factor 1 receptors: a tale of two antigens implicated in Graves’ Disease. J Immunol 181:4397–4405. https://doi.org/10.4049/jimmunol.181.6.4397